Human BioMolecular Atlas Program (HuBMAP) Frequently Asked Questions (FAQs)

We appreciate your interest in the Human BioMolecular Atlas Program (HuBMAP) and hope that you and your team will choose to submit an application. In order to maximize your chances of success, we would like to provide some guidance that may be helpful. For additional clarification of these or other issues, we encourage you to send an email to HuBMAP@mail.nih.gov or talk with the scientific contacts listed in the RFA to which you are applying.

General Questions

1. What is the NIH Common Fund?

2. What is the NIH Common Fund Human Biomolecular Atlas Program (HuBMAP)?

3. How is the program structured?

3a. What is expected to happen during each of the four phases of the program?

4. What is the relationship between HuBMAP and other similar programs?

5. Where can I find more information?

6. Who should I contact with questions?

Science-Related Questions

7. What do you mean by “tissue”, “organ”, and “organ system”?

8. What do you mean by “healthy” human tissue?

9. Will HuBMAP fund projects that do not use “healthy” human tissue?

10. What is a 3D tissue map and a biomolecular atlas?

11. What tissue or organs are within the scope of the program?

12. What tools and technologies are within the scope of the program?

13. What is meant by high resolution, high content, and high-throughput?

13a. What will be considered unresponsive?

13b. Will HuBMAP fund projects using dissociative techniques?

14. What is the difference between Transformative Technology Development and Rapid Technology Implementation initiatives?

RFA-Related Questions

15. Does HuBMAP use the NIH grant mechanism?

16. What are cooperative agreements?

17. What are Other Transaction (OT) awards?

18. Is funding based on a payline?

19. Who is eligible to apply for funding?

20. My organization is an XYZ or I am an ABC investigator. Does that mean I have any special preference or disadvantage?

21. Can work be performed outside the United States?

22. Is there a recommended period of performance and budget level?

23. Can an institution/research team submit more than one application to a one RFA or submit related applications to different RFAs?

24. Can research teams span institutions?

25. What makes a good application for a Common Fund Program?

HuBMAP Consortium Questions

26. What is the HuBMAP Consortium?

27. What is the HUBMAP Steering Committee?

28. Who participates in the HUBMAP Steering Committee?

29. Who are the external program consultants?

30. What role does the NIH have in the HuBMAP Consortium?

30a. How will investigators be expected to participate in the Consortium?

Award-Related Questions

31. What are the plans for data and resource sharing for this program?

31a. What are the expectations for data security and privacy?

32. Are milestones the same as specific aims?

33. Can changes be made to the Research Plan during the project period?

34. Can HuBMAP select only certain portions of an application to fund?

RFA Specific Questions

TTD: What tissues can projects propose?

TTD: Is preliminary data required?

TMC: Are there preferred tissues?

HIVE: What are the expectation for data archiving?

HIVE: What Consortium-building and community-engagement activities are encouraged?

DP: When will the demonstration projects (DPs) start?

This page last reviewed on January 25, 2018